Some evidence suggests that the bioflavonoid naringen may interact with medications in the calcium channel blocker family, increasing blood levels of the drug.
This may necessitate a reduction in drug dosage.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Bar-Or D and Gasiel Y. Calcium and calciferol antagonise effect of verapamil in atrial fibrillation.
Br Med J (Clin Res Ed)
Hariman RJ, Mangiardi LM, McAllister RG Jr, et al. Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses.
Guadagnino V, Greengart A, Hollander G, et al. Treatment of severe left ventricular dysfunction with calcium chloride in patients receiving verapamil.
J Clin Pharmacol.
Salerno DM, Anderson B, Sharkey PJ, et al. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment.
Ann Intern Med.
Luscher TF, Noll G, Sturmer T, et al. Calcium gluconate in severe verapamil intoxication.
N Engl J Med.
Kuhn M and Schriger DL. Low-dose calcium pretreatment to prevent verapamil-induced hypotension.
Am Heart J.
Shinozuka K, Umegaki K, Kubota Y, et al. Feeding of
extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats.
Yeum CH, Choi JS. Effect of naringin pretreatment on bioavailability of verapamil in rabbits.
Arch Pharm Res.